105 related articles for article (PubMed ID: 12956426)
1. Inhibition of intraperitoneal tumor growth of human ovarian cancer cells by bi- and trifunctional inhibitors of tumor-associated proteolytic systems.
Krol J; Kopitz C; Kirschenhofer A; Schmitt M; Magdolen U; Krüger A; Magdolen V
Biol Chem; 2003 Jul; 384(7):1097-102. PubMed ID: 12956426
[TBL] [Abstract][Full Text] [Related]
2. Novel bi- and trifunctional inhibitors of tumor-associated proteolytic systems.
Krol J; Sato S; Rettenberger P; Assfalg-Machleidt I; Schmitt M; Magdolen V; Magdolen U
Biol Chem; 2003 Jul; 384(7):1085-96. PubMed ID: 12956425
[TBL] [Abstract][Full Text] [Related]
3. High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nude mice.
Lutz V; Reuning U; Krüger A; Luther T; von Steinburg SP; Graeff H; Schmitt M; Wilhelm OG; Magdolen V
Biol Chem; 2001 May; 382(5):789-98. PubMed ID: 11517932
[TBL] [Abstract][Full Text] [Related]
4. [Recombinant adenovirus-mediated overexpression of TIMP-1 effectively suppresses hepatocellular carcinoma cell line HepG2 in vitro and in vivo].
Xia D; Xu L; Fu H; Qi XL; Quan Y; Yan LN
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):813-7. PubMed ID: 18396636
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A
Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317
[TBL] [Abstract][Full Text] [Related]
6. TIMP-1 antisense gene transfection attenuates the invasive potential of pancreatic cancer cells in vitro and inhibits tumor growth in vivo.
Bloomston M; Shafii A; Zervos E; Rosemurgy AS
Am J Surg; 2005 Jun; 189(6):675-9. PubMed ID: 15910719
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.
Zhang J; Wang B
Gynecol Oncol; 2006 Oct; 103(1):199-206. PubMed ID: 16624393
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells.
Prezas P; Arlt MJ; Viktorov P; Soosaipillai A; Holzscheiter L; Schmitt M; Talieri M; Diamandis EP; Krüger A; Magdolen V
Biol Chem; 2006 Jun; 387(6):807-11. PubMed ID: 16800744
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3.
Tran PL; Vigneron JP; Pericat D; Dubois S; Cazals D; Hervy M; DeClerck YA; Degott C; Auclair C
Cancer Gene Ther; 2003 Jun; 10(6):435-44. PubMed ID: 12768188
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
[TBL] [Abstract][Full Text] [Related]
11. A novel type of bifunctional inhibitor directed against proteolytic activity and receptor/ligand interaction. Cystatin with a urokinase receptor binding site.
Muehlenweg B; Assfalg-Machleidt I; Parrado SG; Bürgle M; Creutzburg S; Schmitt M; Auerswald EA; Machleidt W; Magdolen V
J Biol Chem; 2000 Oct; 275(43):33562-6. PubMed ID: 10913110
[TBL] [Abstract][Full Text] [Related]
12. TIMP-3 gene transfection suppresses invasive and metastatic capacity of human hepatocarcinoma cell line HCC-7721.
Zhang H; Wang YS; Han G; Shi Y
Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):487-91. PubMed ID: 17897911
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor growth and induction of apoptosis in prostate cancer cell lines by overexpression of tissue inhibitor of matrix metalloproteinase-3.
Zhang L; Zhao L; Zhao D; Lin G; Guo B; Li Y; Liang Z; Zhao XJ; Fang X
Cancer Gene Ther; 2010 Mar; 17(3):171-9. PubMed ID: 19798124
[TBL] [Abstract][Full Text] [Related]
14. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
[TBL] [Abstract][Full Text] [Related]
15. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
[TBL] [Abstract][Full Text] [Related]
16. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
17. Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
Wang L; Madigan MC; Chen H; Liu F; Patterson KI; Beretov J; O'Brien PM; Li Y
Gynecol Oncol; 2009 Aug; 114(2):265-72. PubMed ID: 19450871
[TBL] [Abstract][Full Text] [Related]
18. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.
Henic E; Sixt M; Hansson S; Høyer-Hansen G; Casslén B
Gynecol Oncol; 2006 Apr; 101(1):28-39. PubMed ID: 16263158
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivo.
Rigg AS; Lemoine NR
Cancer Gene Ther; 2001 Nov; 8(11):869-78. PubMed ID: 11773977
[TBL] [Abstract][Full Text] [Related]
20. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
